Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Standardization and Validation Issues of the ELISPOT Assay

Go back to Resources

Standardization and Validation Issues of the ELISPOT Assay

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Retinal Risk Factors and Progression to Geographic Atrophy in Age-Related Macular Degeneration

Go back to Resources

Retinal Risk Factors and Progression to Geographic Atrophy in Age-Related Macular Degeneration

Authors:

Secondary:

Location:

URL:

Go back to Resources

Responsiveness of the National Eye Institute Visual Function Questionnaire to Progression to Advanced Age-Related Macular Degeneration, Vision Loss, and Lens Opacity: AREDS Report No. 14

Go back to Resources

Responsiveness of the National Eye Institute Visual Function Questionnaire to Progression to Advanced Age-Related Macular Degeneration, Vision Loss, and Lens Opacity: AREDS Report No. 14

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Recurrence of Membranoproliferative Glomerulonephritis Type II in Renal Allografts: The North American Pediatric Renal Transplant Cooperative Study Experience

Go back to Resources

Recurrence of Membranoproliferative Glomerulonephritis Type II in Renal Allografts: The North American Pediatric Renal Transplant Cooperative Study Experience

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Ongoing, Prospective Multicenter Safety Study of Subcutaneous Amifostine for Non-Small Cell Lung Cancer (NSCLC)

Go back to Resources

Ongoing, Prospective Multicenter Safety Study of Subcutaneous Amifostine for Non-Small Cell Lung Cancer (NSCLC)

Authors:

Secondary:

Location:

Go back to Resources

Ongoing Prospective Multicenter Safety Study of Subcutaneous Cytoprotectant Amifostine for Head and Neck Carcinoma

Go back to Resources

Ongoing Prospective Multicenter Safety Study of Subcutaneous Cytoprotectant Amifostine for Head and Neck Carcinoma

Authors:

Secondary:

Location:

Go back to Resources

Group Sequential Monitoring for Trend in Proportions with Likelihood Ratio Test Statistic

Go back to Resources

Group Sequential Monitoring for Trend in Proportions with Likelihood Ratio Test Statistic

Authors:

Secondary:

Location:

Go back to Resources

Follow-up Study of HTLV-I Viral Markers in Children in Jamaica

Go back to Resources

Follow-up Study of HTLV-I Viral Markers in Children in Jamaica

Authors:

Secondary:

Location:

URL:

Go back to Resources

Evaluation of Predictive Markers of HTLV-I Associated Disease in Jamaica

Go back to Resources

Evaluation of Predictive Markers of HTLV-I Associated Disease in Jamaica

Authors:

Secondary:

Location:

URL:

Go back to Resources

Effect of Different Vaccination Schedules on Excretion of Oral Poliovirus Vaccine Strains

Go back to Resources

Effect of Different Vaccination Schedules on Excretion of Oral Poliovirus Vaccine Strains

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 154
  • Page 155
  • Page 156
  • Page 157
  • Current page 158
  • Page 159
  • Page 160
  • Page 161
  • Page 162
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification